Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 9/20 | 0.84 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.44 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.44 |
| ▸ | ITGAL | P20701 | 1/20 | 0.44 |
| ▸ | ECE1 | P42892 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TACR1 | P25103 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL737830 | 1.00 | GHSR (0.84) | GHSROPRM1MAPK1SMN1; SMN2ITGB2 | |
| SCHEMBL737041 | 0.93 | GHSR (0.70) | GHSRMEN1KMT2ATACR1 | |
| SCHEMBL739061 | 0.90 | GHSR (0.84) | GHSROPRM1ITGB2ICAM1ITGAL | |
| SCHEMBL736960 | 0.90 | GHSR (0.84) | GHSROPRM1ITGB2ICAM1ITGAL | |
| SCHEMBL738004 | 0.87 | GHSR (0.63) | GHSRTACR1 | |
| SCHEMBL739284 | 0.87 | GHSR (0.63) | GHSRTACR1 | |
| SCHEMBL739684 | 0.84 | GHSR (0.85) | GHSROPRM1MAPK1SMN1; SMN2ECE1 | |
| SCHEMBL738032 | 0.84 | GHSR (0.85) | GHSROPRM1MAPK1SMN1; SMN2ECE1 | |
| SCHEMBL738947 | 0.84 | GHSR (0.59) | GHSRTACR1 | |
| SCHEMBL739671 | 0.84 | GHSR (0.59) | GHSRMEN1KMT2ATACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138218-B2 | Growth hormone secretagogues | IPSEN PHARMA S.A.S. (FR) | 2012-03-20 | — | — | US | disclosed |
| US-20090131478-A1 | Growth Hormone Secretagogues | IPSEN PHARMA S.A.S. (FR) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131478-A1 | Growth Hormone Secretagogues | GHSR, GHRHR, GHITM | GHSR 1/4885OPRM1 3398/4885MAPK1 1685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.